Greenville, SC · Founded 2017 · Privately Held (backing)
Developer of biotech therapeutics designed to improve health by restoring damaged hardened tissue to healthy resilience. Elastrin is based in Greenville, SC and was founded in 2017. Its last reported valuation was $32 million in Nov 2023. It has raised $20.2 million.
Last reported valuation
$32.0M
Oct 2026
Priced at
—
Total raised
$20.2M
Last round
—
Cap table — not yet on record
Elastrin's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Elastrin with a free account
·Watch Elastrin: the Monday email on marks, rounds and moves
